Pathways to precision medicine: deciphering the secrets of physiological and pathological atrial enlargement
Clinical Science · 2024
DOI: 10.1042/cs20241421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2024. Verfasst von Shuai Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX 77030, U.S.A. Hauptthemen laut MEDLINE: Receptor, IGF Type 1, Mice, Transgenic, Heart Atria, Atrial Remodeling. Die Arbeit nennt 14 Literaturangaben. Gefördert von: National Heart, Lung, and Blood Institute (NHLBI).
Abstract (Originalsprache)
Cardiac functional, morphological, and histological analysis, coupled with liquid chromatography and mass spectrometry, of two transgenic mouse models with cardiomyocyte-specific overexpression of insulin-like growth factor 1 receptor (IGF1R) or a dominant-negative PI3K mutant (DCM-dnPI3K) revealed distinctive functional and molecular profiles during physiological (driven by IGF1R overexpression) and pathological (driven by dn-PI3K overexpression) atrial remodeling. The current study confirmed previously reported findings, including ventricular dilatation and enhanced systolic function with no evidence of arrhythmia in IGF1R model, as well as ventricular hypertrophy and decreased systolic function with intermittent atrial fibrillation in DCM-dnPI3K model. Novel findings obtained from the left atrial (LA) characterization of female mice revealed that physiological atrial enlargement resulted from increased atrial myocyte size and was associated with preserved atrial function, as determined by maintained LA ejection fraction (EF). The proteomic profile of IGF1R transgenic (Tg) mice was enriched for metabolic remodeling and showed a protein expression pattern similar to that of healthy human atria; on the other hand, pathological atrial enlargement resulted from increased atrial fibrosis with normal myocyte size and was associated with impaired atrial function due to a reduced LA EF. The proteomic profile of DCM-dnPI3K mice was enriched to both metabolic and structural remodeling and showed a protein expression pattern similar to that of human AF atria
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX 77030, U.S.A.
- Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, U.S.A.
- Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, U.S.A.
- Department of Medicine, Baylor College of Medicine, Houston, TX 77030, U.S.A.
- Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, U.S.A.
- Center for Space Medicine, Baylor College of Medicine, Houston, TX 77030, U.S.A.
ORCID-Profile: Xander H T Wehrens
Förderung
- National Heart, Lung, and Blood Institute (NHLBI)
Zitieren
APA
Zhao, S., & Wehrens, X. H. T. (2024). Pathways to precision medicine: deciphering the secrets of physiological and pathological atrial enlargement. Clinical Science. https://doi.org/10.1042/cs20241421
Vancouver
Zhao S, Wehrens XHT. Pathways to precision medicine: deciphering the secrets of physiological and pathological atrial enlargement. Clinical Science. 2024. doi:10.1042/cs20241421
BibTeX
@article{Zhao2024,
author = {Zhao, Shuai and Wehrens, Xander H T},
title = {Pathways to precision medicine: deciphering the secrets of physiological and pathological atrial enlargement},
journal = {Clinical Science},
year = {2024},
doi = {10.1042/cs20241421}
}
EUVIMED